Skip to main content
$167.10 -$0.74 (-0.4%)

04:00 PM EST on 01/18/22

Johnson & Johnson (NYSE:JNJ)

CAPS Rating: 4 out of 5

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.

Current Price $167.10 Mkt Cap $439.9B
Open $167.10 P/E Ratio 24.60
Prev. Close $167.10 Div. (Yield) $4.24 (2.5%)
Daily Range $166.01 - $167.72 Volume 762
52-Wk Range $151.47 - $179.92 Avg. Daily Vol. 7,662,525

Caps

How do you think NYSE:JNJ will perform against the market?

Add Stock to CAPS Watchlist

All Players

13,603 Outperform
513 Underperform
 

All-Star Players

2,472 Outperform
54 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:JNJ Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFkodyk123 (33.10)
Submitted August 06, 2021

Johnson & Johnson is a fairly valued Dividend King that offers the prospect of mid to upper-single-digit annual earnings growth to go along with its market-beating 2.5% yield.

acegdl007 (77.61)
Submitted January 20, 2011

J&J is not a company that has experienced significant growth (in terms of stock price) over the past few years. It has mainly sustained its self on it's brand name recognition that has been significantly tarnished in 2010 due to several recalls.… More

Recent Community Commentary

Read the most recent pitches from players about JNJ.

Recs

1
Member Avatar TMFkodyk123 (33.10) Submitted: 8/6/2021 2:11:18 PM : Outperform Start Price: $171.85 NYSE:JNJ Score: -5.90

Johnson & Johnson is a fairly valued Dividend King that offers the prospect of mid to upper-single-digit annual earnings growth to go along with its market-beating 2.5% yield.

Recs

1
Member Avatar TMFAdriaCimino (< 20) Submitted: 1/14/2021 8:50:20 AM : Outperform Start Price: $158.52 NYSE:JNJ Score: -14.53

J&J has a strong revenue and profit track record -- and a vast product portfolio. So I expect it to win over the long term.

Recs

1
Member Avatar naseerkhan (25.19) Submitted: 1/14/2021 12:16:42 AM : Outperform Start Price: $158.52 NYSE:JNJ Score: -14.53

COVID-19 vaccine finally showing good results

Leaderboard

Find the members with the highest scoring picks in JNJ.

Score Leader

juliojulio

juliojulio (< 20) Score: +177.84

The Score Leader is the player with the highest score across all their picks in JNJ.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
juliojulio < 20 11/21/2008 8/14/2009 Underperform 1Y $38.91 +329.46% +507.30% +177.84 0 Comment
jokester2222 < 20 2/19/2009 Underperform 3W $38.45 +334.61% +491.08% +156.48 0 Comment
Nonnah 31.03 2/19/2009 Underperform 3W $38.76 +331.13% +482.41% +151.28 0 Comment
smjc < 20 3/3/2009 Underperform 3W $33.28 +402.08% +549.24% +147.17 0 Comment
erkleiner < 20 11/24/2008 Underperform NS $40.51 +312.51% +458.83% +146.32 0 Comment
lbrova < 20 10/28/2008 Underperform 5Y $41.86 +299.17% +442.70% +143.53 0 Comment
wickerdude 80.26 1/21/2009 Underperform 3M $39.44 +323.68% +466.98% +143.29 0 Comment
moonleg 25.98 10/27/2008 Underperform 1Y $41.28 +304.79% +441.49% +136.70 0 Comment
elliomik 96.44 10/28/2008 Underperform 3M $41.98 +298.00% +433.37% +135.36 0 Comment
Kstawicki817 < 20 11/25/2008 Underperform NS $39.95 +318.27% +448.58% +130.31 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for JNJ.